Delivery Order SPE2DR25D2006-SPE2DR26F57TS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,592.02 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100 count) on January 13, 2026, with an ultimate completion date of January 14, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's parent...
- The Defense Logistics Agency awarded a delivery order valued at $1,290.28 to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) on January 6, 2026, with an ultimate completion date of January 7, 2026. This contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,902.46 to AmerisourceBergen Drug Corp for the supply of Adderall XR 30 mg capsules (100-count units) on January 22, 2026, with an ultimate completion date of January 23, 2026. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies performance at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $3,659.71 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100 count) on January 29, 2026, with completion scheduled for January 30, 2026. This competitive, non-set-aside award was issued under a firm fixed-price contract structure and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,380.29 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100 count) on January 28, 2026, with an ultimate completion date of January 29, 2026. The contract was awarded on a firm fixed-price basis with no set-aside designation, indicating full and open competition. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,156.08 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100-count units) on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.12 to Amerisourcebergen Drug Corp for 100 capsules of Adderall XR 20 mg on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded task order under a larger pharmaceutical supply vehicle. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its...
- The Defense Logistics Agency awarded a delivery order valued at $1,043.64 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100-count units) on December 19, 2025, with an ultimate completion date of December 22, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $7,634.18 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) with a firm fixed-price structure. The contract, awarded on January 9, 2026, has an ultimate completion date of January 12, 2026 and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,347.39 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) on January 29, 2026, with completion scheduled for January 30, 2026. This firm fixed-price delivery order was issued without a set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57TSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,598.24 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100 count) on January 29, 2026, with an ultimate completion date of January 30, 2026. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally. AmerisourceBergen Drug Corp functions as a critical vendor in the federal medical supply chain, distributing a broad portfolio of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company competes on a full and open basis for federal contracts and maintains significant capability in fulfilling government pharmaceutical procurement requirements for military treatment facilities and other federal medical institutions. This specific delivery order for a neurological medication reflects the company's role in supporting the Defense Health Agency and broader military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/28/26 |